相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between markers of immune response at hospital admission and COVID-19 disease severity and mortality: A meta-analysis and meta-regression
Jaskaran Khinda et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal
Laure Wynants et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19
Wenhua Liang et al.
JAMA INTERNAL MEDICINE (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
Peter M. George et al.
LANCET RESPIRATORY MEDICINE (2020)
Severe Covid-19
David A. Berlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness
Robin Cherian et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Age and Multimorbidity Predict Death Among COVID-19 Patients Results of the SARS-RAS Study of the Italian Society of Hypertension
Guido Iaccarino et al.
HYPERTENSION (2020)
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
Jonas Schulte-Schrepping et al.
CELL (2020)
IL-6-based mortality risk model for hospitalized patients with COVID-19
Rocio Laguna-Goya et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome
Sophie Hue et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Extrapulmonary manifestations of COVID-19
Aakriti Gupta et al.
NATURE MEDICINE (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation
Hans Boesmueller et al.
VIRCHOWS ARCHIV (2020)
Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis
Panagiotis Skendros et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
An inflammatory cytokine signature predicts COVID-19 severity and survival
Diane Marie Del Valle et al.
NATURE MEDICINE (2020)
Scoring systems for predicting mortality for severe patients with COVID-19
Yufeng Shang et al.
ECLINICALMEDICINE (2020)
An interpretable mortality prediction model for COVID-19 patients
Li Yan et al.
NATURE MACHINE INTELLIGENCE (2020)
Activin inhibition limits early innate immune response in rat kidney allografts-a pilot study
Niina K. Palin et al.
TRANSPLANT INTERNATIONAL (2017)
Activins and Inhibins: Roles in Development, Physiology, and Disease
Maria Namwanje et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
Gary S. Collins et al.
ANNALS OF INTERNAL MEDICINE (2015)
Serum activin A and B, and follistatin in critically ill patients with influenza A(H1N1) infection
Rita Linko et al.
BMC INFECTIOUS DISEASES (2014)
The activins and their binding protein, follistatin-Diagnostic and therapeutic targets in inflammatory disease and fibrosis
M. P. Hedger et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Activin, neutrophils, and inflammation: just coincidence?
Paschalis Sideras et al.
SEMINARS IN IMMUNOPATHOLOGY (2013)
Serum activin A and B levels predict outcome in patients with acute respiratory failure: a prospective cohort study
David Morritz de Kretser et al.
CRITICAL CARE (2013)
Activin-A Overexpression in the Murine Lung Causes Pathology That Simulates Acute Respiratory Distress Syndrome
Eirini Apostolou et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair
David M. de Kretser et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Key Role for Activin B in Cellular Transformation after Loss of the von Hippel-Lindau Tumor Suppressor
Ingrid Wacker et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia
Kristian L. Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The structure of the Follistatin:Activin complex reveals antagonism of both type I and type II receptor binding
TB Thompson et al.
DEVELOPMENTAL CELL (2005)
Activin A and follistatin in systemic inflammation
KL Jones et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
分享论文
